First Allied Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

First Allied Advisory Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$249K	Buy	2,237 +102	+5%	+$11.4K	0.01%	977
2020 Q2	$239K	Sell	2,135 -451	-17%	-$44.4K	0.01%	927
2020 Q1	$200K	Sell	2,586 -295	-10%	-$26.1K	0.01%	943
2019 Q4	$270K	Sell	2,881 -69	-2%	-$5.97K	0.01%	984
2019 Q3	$221K	Buy	2,950 +302	+11%	+$25.1K	0.01%	1051
2019 Q2	$232K	Sell	2,648 -89	-3%	-$7.59K	0.01%	1026
2019 Q1	$244K	Sell	2,737 -605	-18%	-$51.5K	0.01%	968
2018 Q4	$238K	Sell	3,342 -30,303	-90%	-$2.44M	0.01%	881
2018 Q3	$3.23M	Buy	33,645 +25,379	+307%	+$2.46M	0.11%	211
2018 Q2	$786K	Sell	8,266 -17	-0.2%	-$1.56K	0.03%	526
2018 Q1	$727K	Buy	8,283 +5,979	+260%	+$546K	0.03%	545
2017 Q4	$195K	Buy	+2,304	New	+$193K	0.01%	1068
2017 Q2	–	Sell	-13,866	Closed	-$962K	–	1202
2017 Q1	$962K	Buy	13,866 +7,439	+116%	+$500K	0.05%	388
2016 Q4	$380K	Sell	6,427 -1,237	-16%	-$76.4K	0.02%	689
2016 Q3	$508K	Buy	7,664 +2,940	+62%	+$182K	0.03%	560
2016 Q2	$257K	Buy	4,724 +616	+15%	+$33.8K	0.01%	813
2016 Q1	$212K	Sell	4,108 -204	-5%	-$10.6K	0.01%	881
2015 Q4	$306K	Buy	4,312 +178	+4%	+$12.1K	0.02%	761
2015 Q3	$256K	Sell	4,134 -1,791	-30%	-$141K	0.01%	814
2015 Q2	$496K	Sell	5,925 -174	-3%	-$13.5K	0.02%	617
2015 Q1	$467K	Buy	+6,099	New	+$426K	0.03%	598

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

First Allied Advisory Services's XBI Position: Q3 2020 in Review

First Allied Advisory Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 4.8% in Q3 2020, buying an estimated $11.4K and bringing the position to 2,237 shares worth $249K. The position accounts for 0.01% of the portfolio, ranked #977.

First Allied Advisory Services first reported a position in XBI in Q1 2015 and has held it in 21 quarters since. The position peaked at $3.23M in Q3 2018. 554 funds tracked by Wall St. Rank hold XBI as of Q3 2020.

First Allied Advisory Services held 2,237 shares of State Street SPDR S&P Biotech ETF worth $249K as of Q3 2020.
First Allied Advisory Services bought 102 State Street SPDR S&P Biotech ETF shares in Q3 2020, an estimated $11.4K.
State Street SPDR S&P Biotech ETF made up 0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #977 holding.
First Allied Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and has held it in 21 quarters since.
First Allied Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $3.23M in Q3 2018.
554 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.